Literature DB >> 21460204

EBV-specific CD8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted function.

Camila Macedo1, Steven A Webber, Albert D Donnenberg, Iulia Popescu, Yun Hua, Michael Green, David Rowe, Louise Smith, Maria M Brooks, Diana Metes.   

Abstract

Serial EBV load monitoring of clinically asymptomatic pediatric thoracic organ transplant patients has identified three groups of children who exhibit undetectable (<100 copies/ml), chronic low (100-16,000 copies/ml), or chronic high (>16,000 copies/ml) EBV loads in peripheral blood. Chronic high EBV load patients have a 45% rate of progression to late-onset posttransplant lymphoproliferative disorders. In this article, we report that asymptomatic patients carrying EBV loads (low and high) expressed increased frequencies of EBV-specific CD8(+) T cells, as compared with patients with undetectable EBV loads. Although patients with low viral load displayed EBV-specific CD8(+) T cells with moderate signs of activation (CD38(+/-)/CD127(+/-)), programmed death 1 upregulation and effective IFN-γ secretion, high EBV load carriers showed significant CD38(+) upregulation, features of cellular exhaustion (programmed death 1(+)/CD127(-)) accompanied by a decline in IFN-γ release. Immunopolarization of EBV-specific CD8(+) T cells was skewed from the expected type 1 (IFN-γ) toward type 0 (IFN-γ/IL-5) in patients, and Tr1 (IL-10) in high load carriers. These results indicate the importance of chronic EBV load and of the levels of antigenic pressure in shaping EBV-specific memory CD8(+) T cells. Concomitant phenotypic and functional EBV monitoring is critical for identifying the complex "functional" versus "exhausted" signature of EBV-specific CD8(+) T cells, with implications for immunologic monitoring in the clinic.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21460204      PMCID: PMC4165085          DOI: 10.4049/jimmunol.1001024

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

1.  CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes.

Authors:  Edith M Janssen; Edward E Lemmens; Tom Wolfe; Urs Christen; Matthias G von Herrath; Stephen P Schoenberger
Journal:  Nature       Date:  2003-02-09       Impact factor: 49.962

2.  Increased Ig-null B lymphocytes in the peripheral blood of pediatric solid organ transplant recipients with elevated Epstein-Barr viral loads.

Authors:  Elizabeth Schauer; Steven Webber; Laurence Kingsley; Michael Green; David Rowe
Journal:  Pediatr Transplant       Date:  2008-06-28

3.  CD4+ and CD8+ cell cytokine profiles in neonates, older children, and adults: increasing T helper type 1 and T cytotoxic type 1 cell populations with age.

Authors:  J Chipeta; Y Komada; X L Zhang; T Deguchi; K Sugiyama; E Azuma; M Sakurai
Journal:  Cell Immunol       Date:  1998-02-01       Impact factor: 4.868

Review 4.  EBV the prototypical human tumor virus--just how bad is it?

Authors:  David A Thorley-Lawson
Journal:  J Allergy Clin Immunol       Date:  2005-08       Impact factor: 10.793

5.  Oscillating CD8(+) T cell effector functions after antigen recognition in the liver.

Authors:  Masanori Isogawa; Yoshihiro Furuichi; Francis V Chisari
Journal:  Immunity       Date:  2005-07       Impact factor: 31.745

6.  PD-1 expression on peripheral CD8+ TEM/TEMRA subsets closely correlated with HCV viral load in chronic hepatitis C patients.

Authors:  Tao Shen; Jiajia Zheng; Chunhui Xu; Jia Liu; Weidong Zhang; Fengmin Lu; Hui Zhuang
Journal:  Virol J       Date:  2010-11-12       Impact factor: 4.099

Review 7.  The costimulatory role of TIM molecules.

Authors:  Roselynn Rodriguez-Manzanet; Rosemarie DeKruyff; Vijay K Kuchroo; Dale T Umetsu
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 8.  Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections.

Authors:  Tsvetelina Pentcheva-Hoang; Emily Corse; James P Allison
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

9.  Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8(+) T-cell response.

Authors:  Tania Crough; Chrysa Fazou; Julissa Weiss; Scott Campbell; Miles P Davenport; Scott C Bell; Andrew Galbraith; Keith McNeil; Rajiv Khanna
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

10.  Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection.

Authors:  Elisabeth Amyes; Chris Hatton; Damien Montamat-Sicotte; Nancy Gudgeon; Alan B Rickinson; Andrew J McMichael; Margaret F C Callan
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307

View more
  15 in total

1.  Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired.

Authors:  D Cárdenas; G Vélez; A Orfao; M V Herrera; J Solano; M Olaya; A M Uribe; C Saavedra; M Duarte; M Rodríguez; M López; S Fiorentino; S Quijano
Journal:  Clin Exp Immunol       Date:  2015-09-11       Impact factor: 4.330

Review 2.  The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease.

Authors:  Olivia L Hatton; Aleishia Harris-Arnold; Steven Schaffert; Sheri M Krams; Olivia M Martinez
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

Review 3.  Memory T cells and their exhaustive differentiation in allograft tolerance and rejection.

Authors:  Anna Valujskikh; Xian C Li
Journal:  Curr Opin Organ Transplant       Date:  2012-02       Impact factor: 2.640

Review 4.  Flow cytometry and solid organ transplantation: a perfect match.

Authors:  Orla Maguire; Joseph D Tario; Thomas C Shanahan; Paul K Wallace; Hans Minderman
Journal:  Immunol Invest       Date:  2014       Impact factor: 3.657

Review 5.  The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder.

Authors:  Olivia M Martinez; Sheri M Krams
Journal:  Transplantation       Date:  2017-09       Impact factor: 4.939

6.  LPA5 Is an Inhibitory Receptor That Suppresses CD8 T-Cell Cytotoxic Function via Disruption of Early TCR Signaling.

Authors:  Divij Mathew; Kimberly N Kremer; Pamela Strauch; Gabor Tigyi; Roberta Pelanda; Raul M Torres
Journal:  Front Immunol       Date:  2019-05-28       Impact factor: 7.561

Review 7.  Posttransplant lymphoproliferative disease after lung transplantation.

Authors:  Isabel P Neuringer
Journal:  Clin Dev Immunol       Date:  2013-03-05

8.  Cellular and cytokine correlates of severe dengue infection.

Authors:  Gathsaurie Neelika Malavige; Li-Chieh Huang; Maryam Salimi; Laksiri Gomes; S D Jayaratne; Graham S Ogg
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

9.  Gene expression meta-analysis reveals immune response convergence on the IFNγ-STAT1-IRF1 axis and adaptive immune resistance mechanisms in lymphoma.

Authors:  Matthew A Care; David R Westhead; Reuben M Tooze
Journal:  Genome Med       Date:  2015-09-11       Impact factor: 11.117

10.  Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV+ Patients.

Authors:  Diana M Hernández; Sandra Valderrama; Sandra Gualtero; Catalina Hernández; Marcos López; Maria Victoria Herrera; Julio Solano; Susana Fiorentino; Sandra Quijano
Journal:  Front Immunol       Date:  2018-10-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.